RT Book, Section
A1 Ojeda-Fournier, Haydee
A1 de Guzman, Jade
A1 Ward, Erin
A1 Blair, Sarah L.
A2 Morita, Shane Y.
A2 Balch, Charles M.
A2 Klimberg, V. Suzanne
A2 Pawlik, Timothy M.
A2 Posner, Mitchell C.
A2 Tanabe, Kenneth K.
SR Print(0)
ID 1145759843
T1 Screening for Breast Cancer
T2 Textbook of Complex General Surgical Oncology
YR 2018
FD 2018
PB McGraw-Hill Education
PP New York, NY
SN 9780071793315
LK hemonc.mhmedical.com/content.aspx?aid=1145759843
RD 2024/04/23
AB Breast  cancer  remains  the  most  common  cancer  in  American  women,  excluding  cancers  of  the  skin,  and  accounts  for  29%  of  all  female  cancer  in  the  United  States.  The  lifetime  risk  of  an  American  women  being  diagnosed  with  breast  cancer  is  1  in  8.  The  American  Cancer  Society  (ACS)  estimates  that  in  2016  there  will  be  232,340  cases  of  invasive  breast  carcinoma  and  an  additional  64,640  cases  of  in  situ  disease.1  In  addition,  39,620  deaths  are  estimated  to  occur  in  2016.  Everyone  knows  someone  who  has  been  affected  by  breast  cancer,  and  breast  cancer  advocacy  remains  strong  in  the  public  eye.  Consequently,  breast  cancer  screening  has  become  highly  politicized  in  the  United  States.  Heated  debates  regarding  the  efficacy  of  mammographic  screening  for  breast  cancer  have  become  a  frequent  lay  media  occurrence.